Increasing oversight of API manufacturing through international collaboration

Report on the International API inspection program published

The European Medicines Agency (EMA) and its European and international partners have successfully strengthened their interactions to improve the oversight of active pharmaceutical ingredient (API) manufacturers worldwide, as highlighted in the International API inspection programme report for 2011-2016, published on 12th April.

Read more online
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /